Myrthe de Laat

Research output

Research output per year 2019 2019 2022 2022

• 3 Article

Research output per year

Research output per year

Search results

• 2022

  Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial

  NABOGO steering group, 1 May 2022, In: The Lancet Infectious Diseases. 22, 5, p. 706-717 12 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  23 Citations (Scopus)

• Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in Neisseria gonorrhoeae

  Gubenšek, U., de Laat, M., Foerster, S., Boyd, A. & van Dam, A. P., 1 Mar 2022, In: Antibiotics (Basel, Switzerland). 11, 3, 299.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  5 Citations (Scopus)
• 2019

  Ceftriaxone Reduced Susceptible Neisseria gonorrhoeae in the Netherlands, 2009 to 2017: From PenA Mosaicism to A501T/V Nonmosaicism

  de Laat, M. M., Wind, C. M., Bruisten, S. M., Dierdorp, M., de Vries, H. J. C., Schim van der Loeff, M. F. & van Dam, A. P., Sept 2019, In: Sexually transmitted diseases. 46, 9, p. 594-601 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  9 Citations (Scopus)